27% profit every 20 days?
This is what Nic Chahine averages with his option buys. Not selling covered calls or spreads… BUYING options. Most traders don’t even have a winning percentage of 27% buying options. He has an 83% win rate. Here’s how he does it.
- Walter Investment Management Corp (NYSE:WAC) shares tumbled 33.9 percent to $1.02. Walter Investment Management shares have dropped 76.48 percent over the past 52 weeks, while the S&P 500 index has gained 17.66 percent in the same period.
- CareDx Inc (NASDAQ:CDNA) fell 25.6 percent to $1.60 after the company reported weak preliminary sales for fourth quarter and FY 2016.
- TrovaGene Inc (NASDAQ:TROV) shares dipped 22.9 percent to $1.35. Trovagene reported a Q4 loss of $8.5 million on revenue of $68,000. Piper Jaffray downgraded TrovaGene from Neutral to Underweight.
- Arotech Corporation (NASDAQ:ARTX) shares dropped 22.5 percent to $3.17 after the company posted downbeat Q4 results.
- Avid Technology, Inc. (NASDAQ:AVID) shares fell 18 percent to $4.39. Avid Tech disclosed that it has postponed Q4 earnings conference call to allow auditors to complete 'routine procedures.'
- Digital Power Corporation (NYSE:DPW) declined 16.7 percent to $1.00.
- AXT Inc (NASDAQ:AXTI) shares fell 16 percent to $6.22. AXT reported that an electrical short-circuit fire occurred at its manufacturing production facility.
- Patheon NV (NYSE:PTHN) shares declined 15.7 percent to $26.45 on downbeat quarterly results.
- PFSweb, Inc. (NASDAQ:PFSW) fell 11.7 percent to $6.77. PFSweb reported a Q4 loss of $0.19 per share on revenue of $102.45 million. The company also lowered its FY17 sales forecast.
- Guess?, Inc. (NYSE:GES) shares dropped 10.6 percent to $10.94 after the company reported weaker-than-expected results for its fourth quarter.
- Catalyst Pharmaceuticals Inc (NASDAQ:CPRX) fell 11 percent to $1.38. Catalyst Pharmaceuticals reported a Q4 loss of $0.05 per share.
- Heritage Insurance Holdings Inc (NYSE:HRTG) shares dropped 10 percent to $12.74. Heritage Insurance reported a Q4 loss of $0.09 per share on revenue of $102.80 million.
- Inovio Pharmaceuticals Inc (NASDAQ:INO) shares declined 9.5 percent to $6.22. Inovio Pharmaceuticals reported a Q4 loss of $0.35 per share on revenue of $8.5 million. Piper Jaffray downgraded Inovio Pharma from Overweight to Neutral.
- Intrepid Potash, Inc. (NYSE:IPI) shares declined 6.7 percent to $1.33. Intrepid Potash reported a proposed public offering of common stock.
- Biogen Inc (NASDAQ:BIIB) shares slipped 5.3 percent to $277.19. Morgan Stanley downgraded Biogen from Overweight to Equal-Weight.
- Conatus Pharmaceuticals Inc (NASDAQ:CNAT) fell 4.5 percent to $4.69 after the company posted a wider-than-expected quarterly loss.
- Masimo Corporation (NASDAQ:MASI) dropped 4.1 percent to $92.51. Piper Jaffray downgraded Masimo from Overweight to Neutral.
- United Therapeutics Corporation (NASDAQ:UTHR) shares fell 4.1 percent to $140.10. Credit Suisse initiated coverage on United Therapeutics with an Underperform rating,
27% profit every 20 days?
This is what Nic Chahine averages with his option buys. Not selling covered calls or spreads… BUYING options. Most traders don’t even have a winning percentage of 27% buying options. He has an 83% win rate. Here’s how he does it.
ENTER TO WIN $500 IN STOCK OR CRYPTO
Enter your email and you'll also get Benzinga's ultimate morning update AND a free $30 gift card and more!